<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00612404</url>
  </required_header>
  <id_info>
    <org_study_id>1312004008</org_study_id>
    <nct_id>NCT00612404</nct_id>
  </id_info>
  <brief_title>Symptoms and Endoscopic Results in Consideration of Pretreatment</brief_title>
  <official_title>Symptoms and Endoscopic Results in Consideration of Pretreatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Under daily routine conditions and without any intervention by the sponsor regarding the
      selection of subjects, diagnostic procedures, therapeutic decisions (medicinal and non-
      medicinal therapy, dose, duration, etc.), routine assessments, the participating physicians
      (i.e. gastroenterologists) are asked to document relevant data in patients with
      gastrointestinal disorders.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2005</start_date>
  <primary_completion_date type="Actual">December 2005</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>to gain insight into the relationship between subjective gastrointestinal symptoms and findings of a laryngopharyngeal-esophagogastric endoscopy with respect to the medicinal pre-therapy;</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>to gain insight into the currently used treatment strategies with esomeprazole depending on endoscopic findings.</measure>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">16255</enrollment>
  <condition>Gastrointestinal Diseases</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>patients with gastrointestinal disorders who need an endoscopy.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        gastroenterologists; specialists
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with gastrointestinal disorders who need an endoscopy.

        Exclusion Criteria:

          -  limitiations; possible risks; warnings; contraindications mentioned in the SPC.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kai Richter, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Medical Department AstraZeneca Germany</affiliation>
  </overall_official>
  <verification_date>January 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 28, 2008</study_first_submitted>
  <study_first_submitted_qc>February 8, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2008</study_first_posted>
  <last_update_submitted>February 8, 2008</last_update_submitted>
  <last_update_submitted_qc>February 8, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 11, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dr Kai Richter</name_title>
    <organization>AstraZeneca Germany</organization>
  </responsible_party>
  <keyword>gastrointestinal disorder</keyword>
  <keyword>endoscopy</keyword>
  <keyword>patient with gastrointestinal disorders for whom an endoscopy is performed and who is treated with esomeprazole afterwards.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastrointestinal Diseases</mesh_term>
    <mesh_term>Digestive System Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

